NEW YORK (
CHANGE IN RATINGS
was added to the Conviction Buy List at Nomura. Valuation is attractive at 13 times CY13E EPS.
was upgraded at Goldman Sachs from Neutral to Buy. $37 price target. Macro data is improving in China, and the company is leveraged to higher PRB prices, Goldman said.
was upgraded at Citigroup to Buy from Neutral. $67 price target. Opportunistic entry point from split-up, Citigroup said.
was initiated with a Neutral rating at Goldman Sachs. $13 price target. Margins will be pressured by lower interest rates, Goldmans said.
Everbank Financial was initiated with an Outperform rating at Keefe, Bruyette & Woods. $14 price target. Company is a well-managed, fast-growing bank, KBW said.
was upgraded at Deutsche Bank from Hold to Buy. $38 price target. Higher sales are driving wider margins, Deutsche said.
was upgraded at Needham from Hold to Buy. $13 price target. Cost improvements should attract value investors, Needham said.
Jack in the Box
was upgraded at Wedbush Securities from Underperform to Neutral. $25 price target. Industry pricing and commodity costs are improving, Wedbush said.
was upgraded at Oppenheimer to Neutral from Underperform. Valuation now reflects headwinds, Oppenheimer said.
was upgraded at Stifel Nicolaus from Hold to Buy. $53 price target. Stock is attractive, following a 12% pullback, Stifel Nicolaus said.
was upgraded at BMO Capital Markets to Outperform from Market Perform. $30 price target. Decline in share price represents buying opportunity, BMO said.
STOCK COMMENTS / EPS CHANGES
estimates were boosted through 2013 at Sterne Agee. Company boosted its guidance, Sterne Agee said. Buy rating and $30 price target.
price target was raised at Morgan Stanley. Shares are now seen reaching $51. Company is realizing higher margins at ABC, and the
movie has performed well, Morgan Stanley said. Overweight rating.
was added to the Conviction Buy List at Goldman Sachs. Selloff in energy names appears overdone, Goldman said. $149 price target.
estimates, price target were raised at Bank of America/Merrill Lynch. Shares are now seen reaching $41. Estimates were also increased, given higher Medicare RACs, BofA/Merrill said. Buy rating.
estimates were lowered at Sterne Agee through 2013. Company is leveraged to slower macro and Windows 8 growth, Sterne Agee said. Neutral rating and $26 price target.
Jack in the Box
numbers were increased at Credit Suisse through 2014. Company is realizing higher margins, Credit Suisse said. Neutral rating and new $25 price target.
price target was boosted at Dahlman Rose. Shares are now seen reaching $55. Neo Materials deal should help stabilize earnings, Dahlman Rose said. Buy rating.
Research In Motion
( RIMM) estimates were cut at Raymond James through 2014. Channel checks suggest lower demand, Raymond James said. Market Perform rating and $15 price target.
estimates were cut at Morgan Stanley through 2012. Pork outlook has worsened, Morgan Stanley said. Equal-weight rating.
estimates, price target reduced at Morgan Stanley. Shares are now seen reaching $44. Estimates also cut, given the company's new guidance, Morgan Stanley said. Equal-weight rating.
was cut from the Conviction Buy List at Goldman Sachs. Prefer high-beta energy names, following the recent pullback, Goldman said.
>To submit a news tip, email:
READERS ALSO LIKE:
and become a fan on
This article was written by a staff member of TheStreet.